Summarized by Masters of Longevity from Lifespan.io.
A preview of a scientific conference gathering researchers and stakeholders to discuss emerging approaches and validation needs for biomarkers of biological aging.
Key Takeaways
- Validated, standardized biomarkers of biological aging are essential to test therapies targeting aging in clinical trials.
- Epigenetic clocks, pace-of-aging measures, multi-omic and AI-based approaches are central tools being advanced and compared.
- Bringing scientists, funders, and regulators together aims to define validation standards and enable biomarkers as approved trial endpoints.
